US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines, Inc. | $162.99 | 3.3% | $34.65B | -27.4 | -77.3% | — | Healthcare | 308.2% | — | ||
| 2 | Incyte Corporation | $98.22 | -0.8% | $19.62B | 15.3 | 2112.5% | — | Healthcare | 43.9% | 21.5% | ||
| 3 | Genmab A/S | $25.27 | -0.5% | $15.51B | 16.4 | -59.7% | — | Healthcare | 17.2% | -34.4% | ||
| 4 | Exelixis, Inc. | $51.91 | -1% | $13.19B | 18.7 | 37.9% | — | Healthcare | 27.4% | 3.3% | ||
| 5 | Nuvalent, Inc. | $123.43 | 0.1% | $9.08B | -21.1 | -38% | — | Healthcare | 63.4% | — | ||
| 6 | ImmunityBio, Inc. | $7.36 | 5.3% | $7.71B | -19.4 | -52.4% | — | Healthcare | 159.2% | 351.5% | ||
| 7 | Merus N.V. | $90.00 | 0% | $6.83B | -26.9 | -36.9% | — | Healthcare | 71.1% | 55.9% | ||
| 8 | CG Oncology, Inc. Common stock | $61.08 | 1.1% | $5.39B | -29.4 | -53.9% | — | Healthcare | 132.4% | 666% | ||
| 9 | ASCENTAGE PHARMA GROUP INTERNATIONAL | $17.48 | 2.3% | $5.28B | -88.3 | 84.4% | — | Healthcare | -51.3% | 264.8% | ||
| 10 | Celcuity Inc. | $87.76 | -0.3% | $4.28B | -23.2 | -28.4% | — | Healthcare | 643.1% | — | ||
| 11 | Erasca, Inc. | $13.67 | -2.2% | $4.25B | -31.1 | -50% | — | Healthcare | 876.4% | — | ||
| 12 | Tango Therapeutics, Inc. | $27.97 | -13.4% | $3.25B | -32.1 | 31.4% | — | Healthcare | 482.7% | 39% | ||
| 13 | Relay Therapeutics, Inc. | $15.88 | 2.1% | $3B | -9.9 | 29.6% | — | Healthcare | 372.6% | 39% | ||
| 14 | Enliven Therapeutics, Inc. | $45.10 | 0.5% | $2.75B | -24.6 | 14.6% | — | Healthcare | 109.1% | — | ||
| 15 | IDEAYA Biosciences, Inc. | $31.23 | -0.1% | $2.74B | -24.4 | 55.4% | — | Healthcare | 42.9% | 3118.1% | ||
| 16 | Arcus Biosciences, Inc. | $24.31 | 0.8% | $2.45B | -7.4 | 24.6% | — | Healthcare | 185.7% | 67.4% | ||
| 17 | Day One Biopharmaceuticals, Inc. | $21.53 | 0% | $2.22B | -20.7 | 4.6% | — | Healthcare | 235.9% | 20.6% | ||
| 18 | Nuvation Bio Inc. | $5.56 | 4.3% | $1.93B | -9.3 | 81.7% | — | Healthcare | 210.6% | 1205.5% | ||
| 19 | Zymeworks Inc. | $23.14 | 0% | $1.7B | -21.4 | 8.1% | — | Healthcare | 83.2% | -13% | ||
| 20 | Tyra Biosciences, Inc. | $28.32 | -2.6% | $1.68B | -14.1 | -33.7% | — | Healthcare | 198.1% | — | ||
| 21 | Syndax Pharmaceuticals, Inc. | $19.00 | -0.2% | $1.68B | -5.8 | 40.3% | — | Healthcare | 96.1% | 396.7% | ||
| 22 | UroGen Pharma Ltd. | $33.57 | 2.3% | $1.64B | -10.5 | 13.5% | — | Healthcare | 125.8% | 52.9% | ||
| 23 | ArriVent BioPharma, Inc. Common Stock | $31.74 | 1.2% | $1.48B | -7.3 | 6.4% | — | Healthcare | 27.5% | — | ||
| 24 | Immunocore Holdings plc | $28.60 | 0.2% | $1.45B | -54.0 | 11.2% | — | Healthcare | -9.8% | 15.6% | ||
| 25 | Xilio Therapeutics, Inc. | $8.79 | 0.5% | $1.44B | -2.1 | 56.1% | — | Healthcare | -5% | 476.7% | ||
| 26 | Inhibrx Biosciences, Inc. | $93.05 | -1.2% | $1.37B | -10.3 | -107.2% | — | Healthcare | 511.8% | 550% | ||
| 27 | Bicara Therapeutics Inc. Common Stock | $23.23 | 1.4% | $1.27B | -9.2 | -68.5% | — | Healthcare | 146.3% | — | ||
| 28 | Monte Rosa Therapeutics, Inc. | $18.31 | -0.5% | $1.19B | -39.8 | -2757.1% | — | Healthcare | 307.8% | -73.1% | ||
| 29 | SELLAS Life Sciences Group, Inc. | $8.05 | 3.9% | $1.15B | -32.2 | 40.3% | — | Healthcare | 412.7% | — | ||
| 30 | Corvus Pharmaceuticals, Inc. | $11.91 | -0.8% | $1B | -22.5 | 43.9% | — | Healthcare | 203.1% | — | ||
| 31 | Kura Oncology, Inc. | $9.93 | 3.8% | $882M | -3.1 | -59.5% | — | Healthcare | 63.9% | 5.4% | ||
| 32 | ORIC Pharmaceuticals, Inc. | $8.49 | -1.6% | $879M | -5.8 | 23% | — | Healthcare | -7.9% | — | ||
| 33 | Janux Therapeutics, Inc. | $14.22 | 0.5% | $867M | -7.8 | -35.3% | — | Healthcare | -37.4% | 131.5% | ||
| 34 | Olema Pharmaceuticals, Inc. | $9.51 | 0.7% | $831M | -5.1 | 1.9% | — | Healthcare | 132% | — | ||
| 35 | Geron Corporation | $1.26 | 2.4% | $808M | -9.7 | 47.9% | — | Healthcare | -18.7% | 68.6% | ||
| 36 | BridgeBio Oncology Therapeutics Inc. | $7.56 | -1.6% | $606M | -1.8 | -289.5% | — | Healthcare | -30.4% | — | ||
| 37 | Crescent Biopharma, Inc. | $17.69 | -2.9% | $488M | -1.4 | -442.8% | — | Healthcare | 21% | — | ||
| 38 | Immix Biopharma, Inc. | $8.72 | -4.5% | $474M | -9.8 | -29.6% | — | Healthcare | 264.9% | — | ||
| 39 | Monopar Therapeutics Inc. | $67.47 | 4.8% | $452M | -36.5 | -30.2% | — | Healthcare | 104.5% | — | ||
| 40 | Aura Biosciences, Inc. | $6.34 | 0.5% | $407M | -3.6 | 6.8% | — | Healthcare | 3.9% | — | ||
Showing 40 of 128 stocks